Real

Health Care · Precision Medicine
Data updated Nov 20, 2026Money ledger: 2 records from 1 sourceFiled 2Full reportReport a mistake

Facts

as of Nov 20, 2026

Exvade transforms cancer treatment by guiding invasive tumor cells into a controllable reservoir for safe removal and real-time analysis—unlocking new possibilities in precision oncology and targeted drug delivery.

Headquarters
Atlanta, United States
Employees
51-200estimated range
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Real: 2 money records, each linked to its source.

$2.4MPublic grants2 public grants
Money innewest first
Grant
Sep 2024 · Grant
$2MPaid
Grant
Aug 2023 · Grant
$399kPaid
Money by yearUSD, rounds and grants
2024$2M1 record
2023$399k1 record
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Atlanta United StatesHeadquarters0
Source: office addresses in postings and company registers

Milestones

Sep 10, 2024
Won a grant $2M · CORDIS
Aug 1, 2023
Won a grant $399k · CORDIS
Each milestone is dated by its source: registers, filings, the press